Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.

The lancet. Gastroenterology & hepatology·2026

Same author

Real-world evidence on medication patterns in inflammatory bowel disease the first decade after diagnosis.

Journal of Crohn's & colitis·2026

Same author

Global patterns of disease progression in inflammatory bowel disease: a comprehensive synthesis of contemporary population-based cohorts.

Gastroenterology report·2026

Same author

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Gut·2026

Same author

Large-scale Clustering of Longitudinal Fecal Calprotectin and C-reactive Protein Profiles in Inflammatory Bowel Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025

Same author

Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study.

Journal of Crohn's & colitis·2025

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Genetics of ulcerative colitis.

Alexandra I Thompson¹, Charlie W Lees

¹Gastrointestinal Unit, Western General Hospital, Edinburgh, UK.

Inflammatory Bowel Diseases

|February 15, 2011

Summary

This summary is machine-generated.

Genome-wide association studies have identified over 60 genetic loci for inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD). Novel insights into UC pathogenesis are emerging, particularly regarding mucosal barrier function and IL10 signaling.

Related Experiment Videos

Last Updated: Jun 4, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Area of Science:

Genetics
Gastroenterology
Immunology

Background:

Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel diseases (IBD) with shared and distinct genetic risk factors.
Genome-wide association (GWA) studies have significantly advanced the understanding of IBD genetic architecture.
Over 60 IBD susceptibility loci have been identified, with some associated with both UC and CD, and others specific to each.

Purpose of the Study:

To summarize the progress in identifying genetic susceptibility loci for IBD, with a focus on UC.
To highlight novel insights into UC pathogenesis derived from recent genetic discoveries.
To emphasize the importance of collaborative efforts and functional studies for future therapeutic development.

Main Methods:

Review of published genome-wide association studies (GWA) and meta-analyses in IBD.
Analysis of susceptibility loci identified for UC and CD, including those specific to each disease.
Identification of genes implicated in UC pathogenesis, such as those affecting mucosal barrier function and IL10 signaling.

Main Results:

Over 60 IBD susceptibility loci have been discovered and replicated.
Approximately one-third of loci are shared between UC and CD, with 21 UC-specific and 23 CD-specific loci.
Genes involved in mucosal barrier function (e.g., ECM1, CDH1, HNF4α, laminin B1) confer UC risk.
E-cadherin represents a genetic link between colorectal cancer and UC.
Impaired IL10 signaling is a key pathway in intestinal inflammation relevant to UC.

Conclusions:

GWA studies have revolutionized IBD genetics, revealing numerous susceptibility loci.
Recent discoveries provide novel insights into UC pathogenesis, particularly concerning barrier function and immune signaling.
International collaboration, large-scale meta-analyses, and functional studies are crucial for translating genetic findings into clinical applications and therapeutics for IBD.